Depression in the geriatric population is a frequents, serious, and potentially reversible
disorder, yet relatively few blinded, controlled, antidepressant trial have been reported. A …

Abstract A 6-week, double-blind, parallel group study compared the efficacy and tolerability
of paroxetine and fluoxetine in 106 depressed geriatric outpatients (age,≥ 65 years) …

During the past 75 years, the proportion of elderly individuals in the USA has grown twice as
fast as the general population. Depression in this age-group occurs four times more …

Background: We attempted to determine baseline characteristics predicting response in a 6-
week, double-blind, geriatric depression trial, which showed a significantly higher remission …

Synopsis The selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor fluoxetine is
an effective antidepressant in elderly patients. Its efficacy is similar to that of other frequently …

Major depression during later life represents a clinical challenge. Conventional
antidepressant pharmacotherapy is relatively less well tolerated in geriatric patients …

Background Despite the high prevalence of depression in elderly patients, few well-
designed, placebo-controlled studies of antidepressants have been conducted in this …

To determine the feasibility and effectiveness of treatments for depressed elderly medical
inpatients, MEDLINE was searched for potentially relevant articles published from January …

The efficacy of paroxetine and fluoxetine and their effects on cognitive and behavioural
function were compared in a 6 week, double-blind, randomized study of 106 elderly …

In a randomized 6-week trial comparing fluoxetine with placebo, the Medical Outcomes
Study 36-Item Short-Form Health Status Survey (SF-36) scales were used to measure the …